Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human INHA Protein, N-His

Catalog #:   YHC13401 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P05111
Protein length: Ser233-Ile366
Overview

Catalog No.

YHC13401

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ser233-Ile366

Predicted molecular weight

17.02 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P05111

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Inhibin alpha chain, INHA

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human INHA protein
References

Physicochemical Reinforcement of Hydrophilic Gelatin Films by Fibroin Nanofibrils Prepared via Cellulose-Assisted Self-Assembly., PMID:40467343

Saliva-based lacosamide monitoring paves the way toward personalized epilepsy pharmacotherapy., PMID:40450138

IFN-α and vitamin B6-induced galectin-9 promotes the immunomodulatory function of human clonal mesenchymal stem cells., PMID:40442825

CD44-targeted RIP3 gene delivery strategy for enhanced cancer therapy via necroptosis and immune modulation., PMID:40436345

Hybrid virtual screening identifies dipyrazole carboxamide derivatives as novel direct InhA inhibitors with antitubercular activity., PMID:40436325

DEHP exposure alters carcinoembryonic antigen family member transcript levels and modulates responses to activin A in the murine placenta., PMID:40435666

Review of Recent Advances in Thiazolidin-4-One Derivatives as Promising Antitubercular Agents (2021-Present)., PMID:40430372

Advances in transcription factor delivery: Target selection, engineering strategies, and delivery platforms., PMID:40425091

Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study., PMID:40420308

Region-based segmental swapping of homologous enzymes for higher cadaverine production., PMID:40405206

Exercise-induced CLCF1 attenuates age-related muscle and bone decline in mice., PMID:40399268

Real-world effectiveness of COVID-19 XBB.1.5 monovalent mRNA vaccine: Analysis over nine months., PMID:40398327

Design, synthesis and in silico molecular modelling studies of 2-Hydrazineyl-2-oxoethyl-4-(1H-pyrrol-1-yb) benzoate derivatives: a potent dual DHFR and ENR-reductase inhibitors with antitubercular, antibacterial and cytotoxic potential., PMID:40388480

Exosomes of Human Fetal Cartilage Progenitor Cells (hFCPCs) Inhibited Interleukin-1β (IL-1β)-Induced Osteoarthritis Phenotype via miR-125b-5p In Vitro., PMID:40372627

Biotransformation of iron oxide nanoparticles and their impact on biokinetics in rats following intratracheal instillation., PMID:40367781

Association Between Childhood Trauma and Anhedonia-Related Symptoms: The Mediation Role of Trait Anhedonia and Circulating Proteins., PMID:40359981

Coumarin hybrids: dual-target candidates for future antimicrobial and antitubercular therapies., PMID:40353302

Bone morphogenetic protein 2 rescues neurogenic abnormalities and angiogenic factors in mice with bilateral cavernous nerve injury., PMID:40349205

Circular RNA, A Molecule with Potential Chemistry and Applications in RNA-based Cancer Therapeutics: An Insight into Recent Advances., PMID:40343623

TRIM22 functions as a scaffold protein for autophagy initiation., PMID:40337095

Evaluation of the therapeutic potential of a Schiff Base Compound: Pharmacokinetic profiling, molecular docking for Enoyl-Acyl carrier protein reductase (InhA), antimicrobial, and anticancer properties., PMID:40316109

Cdkn1a silencing restores myoblast differentiation by inducing selective apoptosis in senescent cells., PMID:40307745

Recent Advances in Alginate Lyase Engineering for Efficient Conversion of Alginate to Value-Added Products., PMID:40293191

Bimodal genomic approach predicting Semaphorin 7A (SEMA7A) as prognostic biomarker in adrenocortical carcinoma., PMID:40291702

Prognostic value of residual cancer burden after neoadjuvant chemotherapy in breast cancer: a comprehensive subtype-specific analysis., PMID:40263332

Regulating human oocyte maturation in vitro: a hypothesis based on oocytes retrieved from small antral follicles during ovarian tissue cryopreservation., PMID:40261459

Physical activity and protein-intake strategies to prevent sarcopenia in older people., PMID:40248876

Exogenous administration of heparin-binding epidermal growth factor-like growth factor improves erectile function in mice with bilateral cavernous nerve injury., PMID:40247713

Unraveling the unique bioactivities of highly purified C-phycocyanin and allophycocyanin., PMID:40241106

Identification of novel inhibitors targeting Mycobacterium abscessus InhA through virtual screening, docking, and molecular dynamic simulations., PMID:40229331

Resveratrol attenuates aging-induced mitochondrial dysfunction and mitochondria-mediated apoptosis in the rat heart., PMID:40226768

Unravelling the Biomolecular Interactions Between Hemoglobin and 2D MXenes: A Breakthrough in Biomedical Approach., PMID:40200682

Is Mycobacterial InhA a Suitable Target for Rational Drug Design?, PMID:40192582

Cytochrome P450 2C19 Genotypes and Clopidogrel in Patients With Ischemic Stroke: A Nonrandomized Clinical Trial., PMID:40184070

A depression-associated protein FKBP5 functions in autophagy initiation through scaffolding the VPS34 complex., PMID:40175715

Expression and distribution of activin-follistatin-inhibin axis in the urinary bladder., PMID:40144023

Bio-Refinery of Organics into Value-Added Biopolymers: Exploring the Effects of Hydraulic Retention Time and Organic Loading Rate on Biopolymer Harvesting from a Biofilm-Based Process., PMID:40137510

Soft Pneumatic Device Designed to Mimic the Periosteal Environment for Regulating the Fate of Mesenchymal Stem Cells., PMID:40123288

Multi-drug resistance and compensatory mutations in Mycobacterium tuberculosis in Vietnam., PMID:40078052

Exploring the Anti-Tubercular Potential of 2-(1H-Pyrazol-1-yl) Pyrimidine: Design, Synthesis, Biological Evaluation and Molecular Docking Studies., PMID:40070150

Isoniazid-Dihydropyrimidinone Molecular Hybrids: Design, Synthesis, Antitubercular Activity, and Cytotoxicity Investigations with Computational Validation., PMID:40067058

Prevalence of katG and inhA mutations associated with isoniazid resistance in Mycobacterium tuberculosis clinical isolates in Cameroon., PMID:40059193

Exploration of quinoxaline triazoles as antimycobacterial agents: design, synthesis and biological evaluation., PMID:40058415

An innovative high-rate biofilm-based process: Biopolymer production and recovery from wastewater organic pollutants., PMID:40056594

Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients., PMID:40044785

CCDC134 enhances ovarian reserve function and angiogenesis by directly interacting with INHA in a mouse model of premature ovarian insufficiency., PMID:40042746

Enhanced delivery of doxorubicin via transferrin-coated arylated gold nanostars for cancer therapy., PMID:40023345

Synthesis, DFT study, in silico ADMET evaluation, molecular docking, and QSAR analysis of new anti-tuberculosis drugs derived from 2-hydroxybenzohydrazide derivatives., PMID:40021588

Repurposing of apoptotic inducer drugs against Mycobacterium tuberculosis., PMID:40016256

Structures of TGF-β with betaglycan and signaling receptors reveal mechanisms of complex assembly and signaling., PMID:40011426

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human INHA Protein, N-His [YHC13401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only